RIN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.720400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.722000E-01
Normal-vs-Stage2
6.775800E-01
Normal-vs-Stage3
5.511800E-01
Normal-vs-Stage4
9.979400E-01
Stage1-vs-Stage2
3.908200E-01
Stage1-vs-Stage3
3.331200E-01
Stage1-vs-Stage4
8.760400E-01
Stage2-vs-Stage3
5.552200E-01
Stage2-vs-Stage4
6.306800E-01
Stage3-vs-Stage4
5.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.731600E-01
Normal-vs-AfricanAmerican
8.656200E-01
Normal-vs-Asian
6.016200E-01
Caucasian-vs-AfricanAmerican
6.583800E-01
Caucasian-vs-Asian
6.547200E-01
AfricanAmerican-vs-Asian
3.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.679400E-01
Normal-vs-Female
8.924400E-01
Male-vs-Female
8.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.930800E-01
Normal-vs-Age(41-60Yrs)
8.066800E-01
Normal-vs-Age(61-80Yrs)
7.420000E-01
Normal-vs-Age(81-100Yrs)
7.109200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.783600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.042800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.688200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.526200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.671600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.461400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.272400E-01
Normal-vs-Daily Drinker
6.106000E-01
Normal-vs-Weekly Drinker
9.924000E-01
Normal-vs-Occasional Drinker
7.318200E-01
Normal-vs-Social Drinker
7.568000E-01
Non Drinker-vs-Daily Drinker
1.851990E-01
Non Drinker-vs-Weekly Drinker
6.219800E-02
Non Drinker-vs-Occasional Drinker
6.440000E-03
Non Drinker-vs-Social Drinker
4.931600E-02
Daily Drinker-vs-Weekly Drinker
3.735600E-01
Daily Drinker-vs-Occasional Drinker
1.043980E-01
Daily Drinker-vs-Social Drinker
2.031600E-01
Weekly Drinker-vs-Occasional Drinker
5.589400E-01
Weekly Drinker-vs-Social Drinker
5.607600E-01
Occasional Drinker-vs-Social Drinker
8.780200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.451000E-01
Normal-vs-Grade 2
8.794400E-01
Normal-vs-Grade 3
8.876400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.380000E-01
Grade 1-vs-Grade 3
9.856000E-01
Grade 1-vs-Grade 4
7.451000E-01
Grade 2-vs-Grade 3
8.401600E-01
Grade 2-vs-Grade 4
8.794400E-01
Grade 3-vs-Grade 4
8.876400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.149600E-01
Normal-vs-NonDiabetic
9.484800E-01
Diabetic-vs-NonDiabetic
1.832800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.353000E-01
Normal-vs-NoPancreatitis
9.370600E-01
Pancreatitis-vs-NoPancreatitis
1.604240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.506600E-01
Normal-vs-N1
6.586600E-01
N0-vs-N1
2.268600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.688400E-01
Normal-vs-TP53-NonMutant
8.937200E-01
TP53-Mutant-vs-TP53-NonMutant
5.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
